Novan Inc Quick Ratio (NOVN) starting from the first quarter 2023 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Novan Inc   (NASDAQ: NOVN)

Novan Inc 's Quick Ratio

NOVN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Novan Inc 's Cash & cash equivalent grew by 1.83 % in the Q1 2023 sequentially, while Current Liabilities decreased, this led to improvement in Novan Inc 's Quick Ratio to 0.29, Quick Ratio remained below Novan Inc average.

Within Major Pharmaceutical Preparations industry 557 other companies have achieved higher Quick Ratio than Novan Inc in first quarter 2023. While Quick Ratio total ranking has improved so far during the Q1 2023 to 3642, from total ranking in the fourth quarter 2022 at 3727.

Explain Quick Ratio?
How much Cash & cash equivalents NOVN´s has?
What are NOVN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NOVN Quick Ratio (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1
Y / Y Current Liabilities Change 231.17 % 217.9 % 181.28 % 281.36 % 54.44 %
Y / Y Cash & cash equivalent Change -64.67 % -73.84 % -75.15 % -43.31 % 8.67 %
Quick Ratio MRQ 0.29 0.27 0.42 0.84 2.68
NOVN's Total Ranking # 3642 # 3727 # 2858 # 2884 # 2885
Seq. Current Liabilities Change -5.36 % 30.23 % -19.5 % 233.79 % -9.15 %
Seq. Cash & cash equivalent Change 1.83 % -17.36 % -60.05 % 5.1 % -24.62 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 558
Healthcare Sector # 1043
Overall Market # 3642


Quick Ratio Statistics
High Average Low
5.67 2.23 0.27
(Jun 30 2021)   (Dec 31 2022)




Financial Statements
Novan Inc 's Current Liabilities $ 44 Millions Visit NOVN's Balance sheet
Novan Inc 's Cash & cash equivalent $ 13 Millions Visit NOVN's Balance sheet
Source of NOVN's Sales Visit NOVN's Sales by Geography


Cumulative Novan Inc 's Quick Ratio

NOVN's Quick Ratio for the trailling 12 Months

NOVN Quick Ratio

 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 226.51 % 194.07 % 159.26 % 129.51 % 49.68 %
Y / Y Cash & cash equivalent TTM Growth -63.01 % -51.33 % -30.63 % 1.37 % 41.66 %
Quick Ratio TTM 0.45 0.72 1.25 2.12 4
Total Ranking TTM # 4576 # 4560 # 1792 # 1768 # 4322
Seq. Current Liabilities TTM Growth 21.97 % 29.52 % 27.08 % 62.64 % 9.85 %
Seq. Cash & cash equivalent TTM Growth -22.95 % -25.8 % -25.05 % -13.68 % 1.38 %

Quick ratio ranking by company, industry and sector >> Back to NOVN Financial Strength Comparisons >> Go to Compare NOVN Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2023 to $43.91 millions, cumulative Quick Ratio decreased to 0.45 below the Novan Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 596 other companies have achieved higher Quick Ratio than Novan Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2022 from 4560 to 4576.

Explain Quick Ratio?
How much Cash & cash equivalents NOVN´s has?
What are NOVN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 597
Healthcare Sector # 1184
Within the Market # 4576


trailing twelve months Quick Ratio Statistics
High Average Low
4.8 2.16 0.45
(Jun 30 2021)   (Mar 31 2023)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Avenue Therapeutics Inc   0.78 $ 8.236  Millions$ 10.604  Millions
Evolus Inc   0.77 $ 31.463  Millions$ 40.678  Millions
Kineta Inc   0.77 $ 9.238  Millions$ 11.960  Millions
Heron Therapeutics Inc   0.77 $ 60.022  Millions$ 77.900  Millions
Ernexa Therapeutics Inc   0.77 $ 5.397  Millions$ 7.020  Millions
Neurosense Therapeutics Ltd  0.76 $ 2.640  Millions$ 3.459  Millions
Nrx Pharmaceuticals Inc   0.75 $ 16.506  Millions$ 22.064  Millions
Contrafect Corporation  0.73 $ 13.891  Millions$ 18.978  Millions
Assertio Holdings inc   0.73 $ 68.603  Millions$ 94.545  Millions
Theratechnologies Inc   0.72 $ 34.097  Millions$ 47.294  Millions
Avalo Therapeutics Inc   0.72 $ 16.750  Millions$ 23.245  Millions
Effector Therapeutics Inc   0.71 $ 19.007  Millions$ 26.652  Millions
Altamira Therapeutics Ltd   0.69 $ 0.617  Millions$ 0.889  Millions
Keenova Therapeutics Plc  0.69 $ 480.000  Millions$ 693.700  Millions
Applied Therapeutics Inc   0.69 $ 22.917  Millions$ 33.251  Millions
Oncorus Inc   0.68 $ 21.217  Millions$ 31.108  Millions
Aquestive Therapeutics Inc   0.67 $ 26.882  Millions$ 40.383  Millions
Abbott Laboratories  0.66 $ 9,532.000  Millions$ 14,530.000  Millions
Lucy Scientific Discovery Inc   0.65 $ 3.426  Millions$ 5.230  Millions
Collegium Pharmaceutical Inc   0.65 $ 269.480  Millions$ 412.702  Millions
Ptc Therapeutics inc   0.65 $ 286.303  Millions$ 441.634  Millions
Akebia Therapeutics Inc   0.64 $ 56.953  Millions$ 88.416  Millions
Inventiva S a   0.64 $ 36.142  Millions$ 56.177  Millions
Cumberland Pharmaceuticals Inc   0.64 $ 16.386  Millions$ 25.549  Millions
Sanofi  0.63 $ 10,193.120  Millions$ 16,068.640  Millions
Ainos Inc   0.61 $ 1.146  Millions$ 1.866  Millions
Lftd Partners Inc   0.61 $ 3.501  Millions$ 5.713  Millions
Quantum Biopharma Ltd   0.60 $ 2.757  Millions$ 4.566  Millions
Morphosys Ag  0.60 $ 177.520  Millions$ 296.027  Millions
Perrigo Company Plc  0.59 $ 553.000  Millions$ 940.100  Millions

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.